{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Flovent+Fluticasone+HFA", "query": { "intervention": "Flovent Fluticasone HFA" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 38, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Flovent+Fluticasone+HFA&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-29T02:47:18.127Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00071552", "title": "Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Qvar", "type": "DRUG" }, { "name": "Flovent Diskus", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "12 Years to 70 Years" }, "enrollment_count": 49, "start_date": "2004-01-31", "completion_date": "2006-07-31", "has_results": false, "last_update_posted_date": "2021-11-24", "last_synced_at": "2026-09-29T02:47:18.127Z", "location_count": 1, "location_summary": "Denver, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00071552" }, { "nct_id": "NCT00393952", "title": "New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone propionate/Formoterol fumarate 250/10", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Fluticasone propionate/Formoterol fumarate 100/10", "type": "DRUG" }, { "name": "Fluticasone propionate 250", "type": "DRUG" }, { "name": "Formoterol fumarate 10", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SkyePharma AG", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 557, "start_date": "2006-06", "completion_date": "2008-04", "has_results": false, "last_update_posted_date": "2011-06-23", "last_synced_at": "2026-09-29T02:47:18.127Z", "location_count": 62, "location_summary": "Pell City, Alabama • Glendale, Arizona • Phoenix, Arizona + 53 more", "locations": [ { "city": "Pell City", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00393952" }, { "nct_id": "NCT00307970", "title": "Impact of Anti-static Chamber/Mask", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "HFA FP MDI", "type": "DRUG" }, { "name": "conventional chamber/mask; anti-static chamber/mask", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "6 Years", "sex": "ALL", "summary": "1 Year to 6 Years" }, "enrollment_count": 12, "start_date": "2003-04", "completion_date": "2003-09", "has_results": false, "last_update_posted_date": "2011-09-20", "last_synced_at": "2026-09-29T02:47:18.127Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00307970" }, { "nct_id": "NCT01397201", "title": "Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Low Dose Inhaled Corticosteroid (ICS)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "BI 54903", "type": "DRUG" }, { "name": "Fluticasone propionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "12 Years to 65 Years" }, "enrollment_count": 30, "start_date": "2011-07-01", "completion_date": "2011-12-23", "has_results": true, "last_update_posted_date": "2022-06-23", "last_synced_at": "2026-09-29T02:47:18.127Z", "location_count": 41, "location_summary": "Fountain Valley, California • Fullerton, California • Huntington Beach, California + 38 more", "locations": [ { "city": "Fountain Valley", "state": "California" }, { "city": "Fullerton", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Mission Viejo", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01397201" }, { "nct_id": "NCT01576718", "title": "A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fp MDPI", "type": "DRUG" }, { "name": "Placebo MDPI", "type": "OTHER" }, { "name": "Flovent Diskus", "type": "DRUG" }, { "name": "albuterol/salbutamol", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 889, "start_date": "2012-04", "completion_date": "2013-10", "has_results": true, "last_update_posted_date": "2018-05-08", "last_synced_at": "2026-09-29T02:47:18.127Z", "location_count": 148, "location_summary": "Birmingham, Alabama • Homewood, Alabama • Goodyear, Arizona + 114 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Homewood", "state": "Alabama" }, { "city": "Goodyear", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01576718" }, { "nct_id": "NCT00394199", "title": "Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone propionate/Formoterol Fumarate 100/10", "type": "DRUG" }, { "name": "Fluticasone propionate 100", "type": "DRUG" }, { "name": "Formoterol fumarate 10", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SkyePharma AG", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 357, "start_date": "2006-06", "completion_date": "2008-02", "has_results": false, "last_update_posted_date": "2011-06-23", "last_synced_at": "2026-09-29T02:47:18.127Z", "location_count": 29, "location_summary": "Birmingham, Alabama • Mission Viejo, California • Orange, California + 26 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Jose", "state": "California" }, { "city": "Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00394199" }, { "nct_id": "NCT00400608", "title": "A Study In Pediatric Subjects With Asthma Using ADVAIR HFA, ADVAIR HFA With Spacer, And ADVAIR DISKUS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "ADVAIR HFA", "type": "DRUG" }, { "name": "ADVAIR DISKUS", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 28, "start_date": "2006-10", "completion_date": "2007-02", "has_results": false, "last_update_posted_date": "2016-10-28", "last_synced_at": "2026-09-29T02:47:18.127Z", "location_count": 3, "location_summary": "Huntington Beach, California • Long Beach, California • Medford, Oregon", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Medford", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00400608" }, { "nct_id": "NCT00633217", "title": "Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Fluticasone Propionate/Salmeterol DISKUS 250/50mcg", "type": "DRUG" }, { "name": "Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a MDI 230/42mcg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 247, "start_date": "2008-03", "completion_date": "2009-02", "has_results": true, "last_update_posted_date": "2016-12-08", "last_synced_at": "2026-09-29T02:47:18.127Z", "location_count": 16, "location_summary": "Jasper, Alabama • Mobile, Alabama • Lafayette, Louisiana + 13 more", "locations": [ { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Lafayette", "state": "Louisiana" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Sunset", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00633217" }, { "nct_id": "NCT00747318", "title": "A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Asthmatic Subjects Who Completed FlutiForm HFA pMDI Study SKY2028-3-005", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "SKP FlutiForm HFA pMDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "SkyePharma AG", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 280, "start_date": "2008-09", "completion_date": "2010-06", "has_results": false, "last_update_posted_date": "2011-06-23", "last_synced_at": "2026-09-29T02:47:18.127Z", "location_count": 10, "location_summary": "Scottsdale, Arizona • Orange County, California • Colorado Springs, Colorado + 7 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Orange County", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Valrico", "state": "Florida" }, { "city": "Elizabeth City", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00747318" }, { "nct_id": "NCT00867737", "title": "Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Advair HFA MDI 115/21", "type": "DRUG" }, { "name": "Symbicort 160/4.5 pMDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allergy and Asthma Center of El Paso", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "12 Years to 45 Years" }, "enrollment_count": 30, "start_date": "2008-09", "completion_date": "2009-09", "has_results": false, "last_update_posted_date": "2009-03-24", "last_synced_at": "2026-09-29T02:47:18.127Z", "location_count": 1, "location_summary": "El Paso, Texas", "locations": [ { "city": "El Paso", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00867737" } ] }